Skip to content

Transcranial stimulation applied to fibromyalgia

Neuromodulation applied to fibromyalgia (neurofibro): double-blind, controlled clinical trial - -: -

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
REBEC
Registry ID
RBR-5xbwjk
Enrollment
Unknown
Registered
2020-06-24
Start date
2018-05-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Interventions

Treatment of fibromyalgia symptoms with transcranial direct current stimulation (ETCC) for 20 minutes. Group 1 (15 participants) with anodic stimulation on M1 and cathodic stimulation on the right sup
Group 2 (15 participants), anodic stimulation on the left M1 and cathodic stimulation on the right supraorbital for 10 consecutive days (except weekend) and sham group (15 participants), following the
Other
E02.331.750

Sponsors

Universidade Federal da Paraíba
Lead Sponsor
Universidade Federal da Paraíba
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Having a diagnosis of fibromyalgia, according to the criteria of the American College of Rheumatology; having been diagnosed at least three months ago; be female; be in the age group between 27 and 58 years old; and signing the Informed Consent Form.

Exclusion criteria

Exclusion criteria: Score below 24 on the Mini Mental State Examination; metal implants located on the head; cochlear implants and cardiac pacemaker; illiterate; pregnant women; history of seizure; and severe depression with a score greater than 35 in the Beck Depression Inventory.

Design outcomes

Primary

MeasureTime frame
Pain intensity, assessed by means of a horizontal line of 10 cm, in which there are graduations ranging from zero to ten, and the participants point out a point that for them best represents their perception of pain intensity, being (0) a in the absence of pain, (1-3) mild pain, (4-7) moderate and (8-10) severe.

Secondary

MeasureTime frame
Electroencephalographic activity, through the EEG with 32 channels, of silver chloride electrodes, fixed on the scalp through an adjustable cap containing holes for the contact of the electrode with the scalp.

Countries

Brazil

Contacts

Public ContactNelson Torro

Universidade Federal da Paraíba

nelsontorro@gmail.com+55 83 32167136

Outcome results

None listed

Source: REBEC (via WHO ICTRP)